Diabetes

The latest diabetes and endocrinology news from UNC Health Care and the UNC School of Medicine.

Diabetes drug lowers risk of cardiovascular complications, kidney disease

Diabetes drug lowers risk of cardiovascular complications, kidney disease

For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug – liraglutide – a much-needed outcome for people with type 2 diabetes.

Diabetes drug lowers risk of cardiovascular complications, kidney disease - Read More…

UNC diabetes expert John Buse featured twice on WRAL

UNC diabetes expert John Buse featured twice on WRAL

Buse led a global clinical trial on the new type-2 diabetes drug iDegLira, and he spoke to the local news station about the best ways to screen for the disease.

UNC diabetes expert John Buse featured twice on WRAL - Read More…

Scientists create painless patch of insulin-producing beta cells to control diabetes

Scientists create painless patch of insulin-producing beta cells to control diabetes

The new “smart cell patch” developed at UNC and NC State is a proof of principle to treat millions of people with type-1 and advanced type-2 diabetes.

Scientists create painless patch of insulin-producing beta cells to control diabetes - Read More…

New type-2 diabetes therapy proves better than traditional insulin injections

New type-2 diabetes therapy proves better than traditional insulin injections

UNC-led global phase-3 clinical trial sets the stage for improved management of a disease that affects nearly 30 million Americans.

New type-2 diabetes therapy proves better than traditional insulin injections - Read More…

Biomedical engineer Zhen Gu receives prestigious Sloan Fellowship

Biomedical engineer Zhen Gu receives prestigious Sloan Fellowship

The joint UNC/NC State researcher also earned a grant from JDRF and Sanofi to further develop glucose responsive insulin therapies for diabetes.

Biomedical engineer Zhen Gu receives prestigious Sloan Fellowship - Read More…

Biomedical engineer Zhen Gu, PhD, tabbed as top young innovator

Biomedical engineer Zhen Gu, PhD, tabbed as top young innovator

The editors of the MIT Technology Review highlighted Gu’s work on a novel way to monitor and treat diabetes.

Biomedical engineer Zhen Gu, PhD, tabbed as top young innovator - Read More…

Diabetes drug metformin’s primary effect is in the gut, not the bloodstream

Diabetes drug metformin’s primary effect is in the gut, not the bloodstream

New study in Diabetes Care suggests new delayed-release metformin could help 40 percent of type 2 diabetes patients that currently can’t take metformin.

Diabetes drug metformin’s primary effect is in the gut, not the bloodstream - Read More…

UNC researchers find two biomarkers linked to severe heart disease

UNC researchers find two biomarkers linked to severe heart disease

The finding published in PLoS One suggests that elevated oxidized LDL cholesterol and fructosamine – a measure of glycated proteins in blood sugar – are signposts for the development of severe coronary disease, especially in females.

UNC researchers find two biomarkers linked to severe heart disease - Read More…

Smart insulin patch could replace painful injections for diabetes

Smart insulin patch could replace painful injections for diabetes

A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check.

Smart insulin patch could replace painful injections for diabetes - Read More…

UNC diabetes researcher featured on WRAL

UNC diabetes researcher featured on WRAL

TV segment focused diabetes prevention and screening and featured John Buse, MD, PhD, chief, Division of Endocrinology, executive associate dean for clinical research.

UNC diabetes researcher featured on WRAL - Read More…

Diabetes researcher earns ADA grant to design nanoparticles to control blood sugar

Diabetes researcher earns ADA grant to design nanoparticles to control blood sugar

The research by Zhen Gu, PhD, assistant professor in the UNC-NCSU joint department of biomedical engineering, aims to improve methods for delivering precise amounts of medications less frequently.

Diabetes researcher earns ADA grant to design nanoparticles to control blood sugar - Read More…

Diabetes researchers urge for new screening and management approach

Diabetes researchers urge for new screening and management approach

By treating people earlier, doctors could help diabetes patients avoid the most severe, life-threatening complications that stem from prolonged periods of elevated blood glucose.

Diabetes researchers urge for new screening and management approach - Read More…

Common diabetes drug not linked to short-term risk of pancreatic cancer

Common diabetes drug not linked to short-term risk of pancreatic cancer

UNC researchers overturn a controversial study about DPP-4 inhibitors – commonly prescribed diabetes medications.

Common diabetes drug not linked to short-term risk of pancreatic cancer - Read More…

Join our #T1Dchat on Twitter – Aug. 19 at 1 p.m. ET!

Join our #T1Dchat on Twitter – Aug. 19 at 1 p.m. ET!

Participating in the chat will be two diabetes experts and co-authors of a new American Diabetes Association position statement on the care of people with type 1 diabetes.

Join our #T1Dchat on Twitter – Aug. 19 at 1 p.m. ET! - Read More…

MUSC and UNC-Chapel Hill join forces to test a diabetes outreach program

MUSC and UNC-Chapel Hill join forces to test a diabetes outreach program

The Bamberg Diabetes Transitional Care Study will utilize cutting-edge iPad technology to explore the impact and feasibility of different diabetes interventions for patients transitioning from the hospital to home.

MUSC and UNC-Chapel Hill join forces to test a diabetes outreach program - Read More…

Buse recognized as leading expert in type 2 diabetes

Buse recognized as leading expert in type 2 diabetes

John B. Buse, MD, PhD, chief of the division of endocrinology and director of the Diabetes Care Center, has been ranked as one of the world’s foremost experts in type 2 diabetes based on an analysis of publications in the National Library of Medicine’s MEDLINE database.

Buse recognized as leading expert in type 2 diabetes - Read More…

UNC and SAS join forces to personalize health care for better outcomes

Collaboration will leverage big data to help providers engage patients to manage diabetes, improve health

UNC and SAS join forces to personalize health care for better outcomes - Read More…

UNC begins clinical trial of EndoBarrier® for treatment of type 2 diabetes

UNC begins clinical trial of EndoBarrier® for treatment of type 2 diabetes

The ENDO Trial is currently enrolling adults between the ages of 21 and 65 who have uncontrolled type 2 diabetes and are obese.

UNC begins clinical trial of EndoBarrier® for treatment of type 2 diabetes - Read More…

Share This: